[1] | Tripathi, M. K . “Comforts in Quality and Production of Goat Milk” J Adv Dairy Res. 3(1), 1-2, 2015. |
|
[2] | Alferez, M. J. M., Barrionuevo, M., Aliaga, L. L., Sanz-Sampelayo, M. R., Lisbona, F., Robles, J. C. and Campos, M. S. “Digestive utilization of goat and cow milk fat in malabsorption syndrome.” J Dairy Res. 68, 451-461, 2001. |
|
[3] | Dierick, N. A., Decuypere, J. A. and Degeyter, I. “(2003). The combined use of whole cuphea seeds containing medium chain fatty acids and an exogenous lipase in piglet nutrition”. Archiv fur Tierernahrung 57, 49-63, 2003. |
|
[4] | Wang, J., Wu, X., Simonavicius, N., Tian, H. and Ling, L. “Medium-chain fatty acids as ligands for orphan G proteincoupled receptor GPR84”. J. Biol. Chem. 281, 34457-34464, 2006. |
|
[5] | Wu, F. Y. and Elsasser, T. H. “Studies on cell growth promoting activity in goat milk.” J. Chinese Agric. Chem. Society 33, 326-332, 1995. |
|
[6] | Bergmann, R. S. D. O., Pereira, M. A., Veiga, S. M. O. M., Schneedorf, J. M., Oliveira, N. D. M. S. and Fiorin, J. E. “Microbial profile of a kefir sample preparations - grains in natura and lyophilized and fermented suspension”. Ciênc. Tecnol.. Ciênc. Tecnol. Aliment., Campinas, 30(4), 1022-1026, 2010. |
|
[7] | Rattray, F. P. and O’Connell, M. J. “Fermented Milks Kefir”. In: Fukay JW, editor. Encyclopedia of Dairy Sciences. 2th ed. Academic Press; San Diego, USA. pp. 518-524, 2011. |
|
[8] | Marquina, D., Santos, A., Corpas, I., Munoz, J., Zazo, J. and Peinado, J. M. “Dietary influence of kefir on microbial activities in the mouse bowel”. Lett Appl Microbiol. 35, 136-140, 2002. |
|
[9] | Zhang, Y. and Zhang, H. “Microbiota associated with type 2 diabetes and its related complications”. Food Science and Human Wellness 2, 167-172, 2013. |
|
[10] | Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H. and Nicholson, J. K. “Understanding the role of gut microbiome–host metabolic signal disruption in health and disease”. Trends Microbiol. 19(7), 349-359, Jul 2011. |
|
[11] | Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R. and Katze, M. G. “ Into the Eye of the Cytokine Storm” Microbiol. Mol. Biol. Rev. 76(1), 16-32 , March 2012. |
|
[12] | Fatima, N., Shameem, M., Nabeela, Khan, P. A. and Khan, H. M. “Correlation of serum IL-4 levels in new and MDR tuberculosis patients.” AJCEM 3(1), 48-51, 2015. |
|
[13] | Hong, E. G., Ko, H. J., Cho, Y. R., Kim, H. J., Ma, Z., Yu, T. Y., Friedline, R. H., Kurt-Jones, E., Finberg, R., Fischer, M. A., Granger, E. L., Norbury, C. C., Hauschka, S. D., William M. Philbrick, W. M., Lee, C. G., Elias, J. A. and Kim, J. K. “ Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response inskeletal muscle” . Diabetes 58, 2525-2535, 2009. |
|
[14] | Pickup, J. C. and Crook, M. A. “Is type II diabetes mellitus a disease of the innate immune system?” Diabetologia 41(10), 1241-1248, Oct 1998. |
|
[15] | Kern, P. A., Ranganathan, S., Li, C., Wood, L. and Ranganathan, G. “Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance”. Am J Physiol Endocrinol Metab. 280(5), E745-E751, May 2001. |
|
[16] | Hotamisligil, G. S., Shargill, N. S. and Spiegelman, B. M. “Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance”. Science 259, 87-91, 1993. |
|
[17] | Trinchieri, G. “Interleukin-10 production by effector T cells: Th1 cells show self control”. JEM . 204 ( 2), 239-243, Feb 2007. |
|
[18] | Cavalcanti, Y. V. N., Brelaz, M. C. A., Neves, J. K. D. A. L., Ferraz, J. C. and Valéria Pereira, V. R. A. ”Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulmonary Medicine 2012, 1-10, 2012. |
|
[19] | Van Exel, E., Gussekloo, J., de Craen, A. J., Frolich, M., Van Der Wiel, B. A., Westendorp, R. G. “Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study”. Diabetes 51, 1088-1092, 2002. |
|
[20] | Pennline, K. J., Roque-Gaffney, E. and Monahan, M. “Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse”. Clin Immunol Immunopathol 71, 169-175, 1994. |
|
[21] | Hadisaputro, S., Djokomoeljanto, R. R. J., Judiono, Soesatyo, M. H. N. E. “The effects of oral plain kefir supplementation on proinflammatory cytokine properties of the hyperglycemia Wistar rats induced by streptozotocin.” Acta Med Indones. 44, 100-104, 2012. |
|
[22] | Stewart, A. G., Dusting, G. J., Giarracca, R. G., Harris, T., Lim, Y. and Sobey, C. G. “ Nitrite is produced by elicited but not by circulating neutrophils.” Mediat Inflamm 2, 349-356, 1993. |
|
[23] | El-Mahmoudy, A., Shimizu, Y., Shiina, T., Matsuyama, H., Nikami , H. and Takewaki, T. “Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. ” Acta Diabetol. 42, 23-30, 2005. |
|
[24] | Jain, S. K., Rains, J. L. and Croad, J. L. “Effect of Chromium Niacinate and Chromium Picolinate Supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats”. Free Radic Biol Med. 43(8), 1124-1131, Oct 2007. |
|
[25] | Galen M. Pieper, G. M. “Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction.” Hypertension. 31, 1047-1060, 1998. |
|
[26] | Fang, F. C. “Mechanisms of Nitric Oxide–related Antimicrobial Activity.” J. Clin. Invest. 99 (12), 2818-2825, Jun 1997. |
|
[27] | Kolios, G., Valatas, V. and Ward, S. G. “Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle”. Immunology 113(4), 427-437, Dec 2004. |
|
[28] | Walker, R., Bone, A. J., Cooke, A. and Baird, J. D. “Distinct macrophage subpopulations in pancreas of prediabetic bb/e rats possible role for macrophages in pathogenesis of IDDM”. Diabetes 37:1301-304, 1988. |
|
[29] | Kasenkas, H., Dinkci, N., Seckin, K., Kinik, O., Gonc, S. “ Antioxidant properties of kefir produced from differentcow and soy milk mixtures.” J. Agric. Sci. 17, 253‐259, 2011. |
|
[30] | Reeves, P. G., Neilsen, F. H. and Fahey, G. C. JR. “AIN-93 purified diets for laboratory rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Formulation of the AIN-76A Rodent Diet.” J. Nutr. 123, 1939-1951, 1993. |
|
[31] | Ghasemi, A., Khalifi, S., Jedi, S. “Streptozotocin-nicotinamide-induced rat model of type 2 diabetes.” Acta Physiol Hung. 101, 408-420, 2014. |
|
[32] | Jain, S., Yadav, H., Sinha, P. R., Naito, Y. and Marotta, F. “Dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei has a protective effect against Salmonella enteritidis infection in mice” Int. J. Immunopathol. Pharmacol. 21 (4), 1025-1033, 2008. |
|
[33] | Keller, J.M., McClellan-Greena, P.D., Lee, A.M., Arendt, M.D., Maier, P.P., Segars, A. L., Whitaker, J.D., Keil, D. E., and Peden-Adams, M.M. “Mitogen-induced lymphocyte proliferation in loggerhead sea turtles: comparison of methods and effects of gender, plasma testosterone concentration, and body condition on immunity.” Vet. Immunol. Immunopathol. 103, 269-281, 2005. |
|
[34] | Garcıa, D., Delgado, R., Ubeira, F. M. and Leiro, J. “Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin. Int Immunopharmacol. 2, 797-806, 2002. |
|
[35] | Zykova, S. N., Jenssen, T. G., Berdal, M., Olsen, R., Myklebust, R. and Seljelid, R. “Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II–like db/db mice. Diabetes 49, 1451-1458, 2000. |
|
[36] | Titheradge, M. A. “Nitric Oxide Protocols.” Humana Press Inc., Totowa, New Jersey. 1998. |
|
[37] | Warif, N. M. A., Ayob, A. A., Razali, W. M W., Budin, S. B., Zainalabidin, S. and Mohamed, J. “Effects of Hibiscus sabdariffa Linn. aqueous extract on oxidative stress and T lymphocyte.population in spleen of streptozotocin-induced diabetic rats.” Jurnal Sains Kesihatan Malaysia 12 (1), 15-21, 2014. |
|
[38] | Maher M Al-Enazi. “Combined therapy of rutin and silymarin has more protective effects on streptozotocin-induced oxidative stress in rats.” JAPS. 4 (1), 21- 28, Jan 2014. |
|
[39] | Lee, S. I., Kim, J. S., Oh, S. H., Park, K. Y., Lee, H. G. and Kim, S. D. “Antihyperglycemic effect of Fomitopsis pinicola extracts in streptozotocin-induced diabetic rats.” J Med Food. 11(3), 518-24, Sept 2008. |
|
[40] | Muller, Y. D., Golshayan, D., Ehirchiou, D., Wyss, J. C., Giovannoni, L., Maier, R., Serre-Beiner, V., Yung, G. P., Morel, P., Buhler, L. H. & Seebach, J. D. “Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and relative increase of T regulatory cells.” Diabetes 60(9), 2331-2340, 2011. |
|
[41] | Gaulton, G. N., Schwartz, J. L., Eardley, D. D. “Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.” Diabetologia 28, 769-775, 1985. |
|
[42] | Martinez-Villaluenga, C., Torino, M. I., Martín, V., Arroyo, R., Garcia-Mora, P., Pedrola, I. E., Vidal-Valverde, C., Rodriguez, J. M. and Frias, J. “Multifunctional properties of soy milk fermented by Enterococcus faecium strains isolated from raw soy milk.” J Agric Food Chem. 60(41), 10235-10244, Oct 2012. |
|
[43] | Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T. and Zilmer, M. “Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects.” Br J Nutr. 90(2), 449-456, Aug 2003. |
|
[44] | Jain, S., Yadav, H. and Sinha, P. R. “Probiotic dahi containing Lactobacillus casei protects against Salmonella enteritidis infection and modulates immune response in mice.” J Med Food. 12(3), 576-583, Jun 2009. |
|
[45] | Maroof, H., Hassan, Z. M., Mobarez, A. M. and Mohamadabadi, M. A. “Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol., 1-12, Jun 2012. |
|
[46] | Rubinstein, R., Genaro, A. M., Motta, A., Cremaschi, G. and Wald, M. R. Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose. Clin Exp Immunol. 154, 235-246, 2008. |
|
[47] | Salih, S. F. “Lymphocytes apoptosis in type 2 diabetes mellitus.” Iraqi J. Comm. Med. 4, 330-332, Oct 2012. |
|
[48] | Gomes, A. C., Bueno, A. A., de Souza, R. G. M. and João Felipe Mota. Gut microbiota, probiotics and diabetes.” J. Nutr. 13(60), 1-13, 2014. |
|
[49] | Lee, C.C. and Liu, S. “Role of inflammatory cytokines in type 2 di abetes.” Review of Endocrinology, 19-21, Feb 2008. |
|
[50] | Carasi, P., Racedo, S. M., Serradell, M. A., Jacquot, C. and Urdaci, M. C. “Impact of kefir derived lactobacillus kefiri on the mucosal immune response and gut microbiota.” J Immunol Res. 1-12, 2015. |
|
[51] | Hashem, R. M., Mahmoud, M. F., El-Moselhy, M. A. and Soliman, H. M. “Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis.” Eur J Gastroenterol Hepatol. 20(10), 995-1001, Oct 2008. |
|
[52] | Kang, J. W., Choi, S. C., Cho, M. C., Kim, H. J., Kim, J. H., Lim, J. S., Kim, S. H., Han, J. Y. and Yoon, D. Y. “A proinflammatory cytokine interleukin-32β promotes the production of an anti-inflammatory cytokine interleukin-10.” Immunology . 128(1 Pt 2), e532–e540, Sept 2009. |
|
[53] | Hsieh, F. C., Lee, C. L., Chai, C. Y., Chen, W. T., Lu, Y. C. and Wu, C. S. “Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats.” J Nutr Metab. 10(35), 1-14, 2013. |
|
[54] | Lescheid, D. W. “Probiotics as regulators of inflammation”. Funct. Food Health Dis. 4(7), 299-311, 2014. |
|
[55] | Radhika, P., Annapurna, A. and Rao, S. N. “Immunostimulant, cerebroprotective & nootropic activities of Andrographis paniculata leaves extract in normal & type 2 diabetic rats”. Indian J Med Res. 135, 636-641, May 2012. |
|
[56] | Thomas, C. M. and Versalovic, J. “Probiotics-host communication: Modulation of signaling pathways in the intestine”. Gut Microbes, 1(3), 148-163, 2010. |
|
[57] | Aritrina, P. “The effect of kefir combination from goat milk and soy milk on plasma tumor necrosis factor alpha (TNF-α) and inducible nitric oxide gene expression of hepar in rats induced with Streptozotocin and nicotineamide.” Thesis. Faculty of Medicine, Universitas Gadjah Mada., Indonesia. 2014. |
|
[58] | Foley, E. and O’Farrell, P. H.“Nitric oxide contributes to induction of innate immune responses to Gram-negative bacteria in Drosophila”. Genes & Development 17, 115-125, 2003. |
|
[59] | Ibiza, S., and Serrador, J. M. “The role of nitric oxide in the regulation of adaptive immune responses” Immunología 27 (3), 103-117, 2008. |
|
[60] | Bogdan, C. “Nitric oxide and the immune response”. Nat. Immunol. 2(10), 907-916, Oct 2001. |
|
[61] | Chang, P. V., Hoa, L., Offermanns, S. and Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA, 111(6), 2247-2252, 2014. |
|
[62] | Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L. and Akira, S. “Role of toll-like receptor 1 in mediating immune response to microbial lipoproteins.” J. Immunol. 169, 10-14, 2002. |
|
[63] | Villena, J. and Kitazawa, H. “Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937.” Frontiers in Immunology, 4, 1-12, Jan 2014. |
|
[64] | Stempelj, M., Kedinger, M., Augenlicht, L. and Klampfer, L. “Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate.” J Biol Chem., 282, 9797-9804, March 2007. |
|
[65] | Nathan, C. and Xie, Q. W. 1994. “Regulation of biosynthesis of nitric oxide.” J. Biol. Chem. 269, 13725-13728, 1994. |
|
[66] | Itoh, T., Miyake, Y., Onda, A., Kubo, J., Ando, M., Tsukamasa, Y. and Takahata, M. “Immunomodulatory effects of heat-killed Enterococcus faecalis TH10 on murine macrophage cells” Microbiology Open, 1(4), 373-380, 2012. |
|
[67] | Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez-Llorente, C. and Gil, A. “Probiotic mechanisms of action. Ann Nutr Metab., 61, 160-174, 2012. |
|
[68] | Hassa, P. O., Haenni, S. S., Buerki, C., Meier, N. I., S. Lane, W. S., Owen, H., Gersbach, M., Imhof , R. and Hottiger, M. O. “Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappa B-dependent transcription.” J Biol Chem., 280, 40450-4046, Dec 2005. |
|
[69] | Kassan, M., Choi, S. K., Galán, M., Bishop, A., Umezawa K., Trebak, M., Belmadani, S. and Matrougui , K. “Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. ” Diabetes, 62(6), 2078-87, Jun 2013. |
|